CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-30 | Quartel Adrian W Chief Medical Officer | Sale 10b5-1 | −4,533 | $8.83 | $40K | 9,723 |
| 2026-01-30 | Quartel Adrian W Chief Medical Officer | Option exercise · Restricted Stock Unit 10b5-1 | −11,333 | 22,667 | ||
| 2026-01-30 | Thompson Rahsaan Chief Legal & Compliance | Option exercise 10b5-1 | +11,333 | 53,999 | ||
| 2026-01-30 | Thompson Rahsaan Chief Legal & Compliance | Sale 10b5-1 | −4,080 | $8.83 | $36K | 49,919 |
| 2026-01-30 | Thompson Rahsaan Chief Legal & Compliance | Option exercise · Restricted Stock Unit 10b5-1 | −11,333 | 22,667 | ||
| 2026-01-30 | Sangiovanni Timothy J. SVP, Finance & Corp Controller | Option exercise 10b5-1 | +6,333 | 22,674 | ||
| 2026-01-30 | Sangiovanni Timothy J. SVP, Finance & Corp Controller | Sale 10b5-1 | −1,750 | $8.82 | $15K | 20,924 |
| 2026-01-30 | Sangiovanni Timothy J. SVP, Finance & Corp Controller | Option exercise · Restricted Stock Unit 10b5-1 | −6,333 | 12,667 | ||
| 2026-01-29 | Schafer Joshua CCO | Grant or award · Restricted Stock Unit 10b5-1 | +37,500 | 37,500 | ||
| 2026-01-29 | Schafer Joshua CCO | Grant or award · Stock Option (right to buy) 10b5-1 | +75,000 | 75,000 | ||
| 2026-01-29 | Quartel Adrian W Chief Medical Officer | Grant or award · Restricted Stock Unit 10b5-1 | +37,500 | 37,500 | ||
| 2026-01-29 | Quartel Adrian W Chief Medical Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +75,000 | 75,000 | ||
| 2026-01-29 | Thompson Rahsaan Chief Legal & Compliance | Grant or award · Restricted Stock Unit 10b5-1 | +37,500 | 37,500 | ||
| 2026-01-29 | Thompson Rahsaan Chief Legal & Compliance | Grant or award · Stock Option (right to buy) 10b5-1 | +75,000 | 75,000 | ||
| 2026-01-29 | McFarlane Neil F. President and CEO | Grant or award · Restricted Stock Unit 10b5-1 | +125,000 | 125,000 | ||
| 2026-01-29 | McFarlane Neil F. President and CEO | Grant or award · Stock Option (right to buy) 10b5-1 | +250,000 | 250,000 | ||
| 2025-12-31 | Clifton R. LaDuane Former CFO & Treasurer | Option exercise | +140,667 | 192,028 | ||
| 2025-12-31 | Clifton R. LaDuane Former CFO & Treasurer | Shares withheld for taxes | −48,513 | $8.96 | $435K | 143,515 |
| 2025-12-31 | Clifton R. LaDuane Former CFO & Treasurer | Option exercise · Restricted Stock Unit | −86,667 | 0 | ||
| 2025-12-31 | Clifton R. LaDuane Former CFO & Treasurer | Option exercise · Restricted Stock Unit | −34,000 | 0 |
Page 3 of 9 · 166 trades